» Articles » PMID: 30587502

A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pancreatic Cancer

Overview
Date 2018 Dec 28
PMID 30587502
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aim: Pancreatic cancer (PC) is currently the fourth leading cause of cancer-related mortality worldwide. Peripheral blood mononuclear cells (PBMCs) is a subpopulation of accessible and functional immune cells. Comparative analysis of the proteome of PBMCs can help us elucidate the mechanism of disease and find potential biomarkers for diagnosis.

Materials And Methods: PBMCs were collected from healthy individuals, patients with benign diseases, and pancreatic cancer. iTRAQ-2DLC-MS/MS and SWATH methodologies were applied to make a comparative proteomics analysis of PBMCs.

Results: A total of 3,357 proteins with a false discovery rate (FDR) <1% were identified, of which 114 proteins were found dysregulated in the PC group. An extensive SWATH library was constructed which showed a potential application for large scale clinical sample analysis.

Conclusion: A PBMCs proteome with extensive protein representation was achieved, which will potentially allow the identification of novel biomarkers for PC.

Citing Articles

Proteomics: Unraveling the Cross Talk Between Innate Immunity and Disease Pathophysiology, Diagnostics, and Treatment Options.

Luz I, Takaya R, Ribeiro D, Castro M, Fontes W Adv Exp Med Biol. 2024; 1443:221-242.

PMID: 38409424 DOI: 10.1007/978-3-031-50624-6_12.


Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies.

Challa K, Paysan D, Leiser D, Sauder N, Weber D, Shivashankar G NPJ Precis Oncol. 2023; 7(1):135.

PMID: 38092866 PMC: 10719365. DOI: 10.1038/s41698-023-00484-8.


Proteomics-Driven Biomarkers in Pancreatic Cancer.

Ramalhete L, Vigia E, Araujo R, Marques H Proteomes. 2023; 11(3).

PMID: 37606420 PMC: 10443269. DOI: 10.3390/proteomes11030024.


LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p.

Li L, Ai R, Yuan X, Dong S, Zhao D, Sun X J Hepatocell Carcinoma. 2023; 10:863-881.

PMID: 37313303 PMC: 10259583. DOI: 10.2147/JHC.S410891.


A complementary approach for genetic diagnosis of inborn errors of immunity using proteogenomic analysis.

Sakura F, Noma K, Asano T, Tanita K, Toyofuku E, Kato K PNAS Nexus. 2023; 2(4):pgad104.

PMID: 37077884 PMC: 10109033. DOI: 10.1093/pnasnexus/pgad104.


References
1.
Wang W, Liu X, Liu L, Jin D, Yang P, Wang X . Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-based quantitative proteomics. J Proteomics. 2013; 84:52-60. DOI: 10.1016/j.jprot.2013.03.031. View

2.
Shelton C, Umapathy C, Stello K, Yadav D, Whitcomb D . Hereditary Pancreatitis in the United States: Survival and Rates of Pancreatic Cancer. Am J Gastroenterol. 2018; 113(9):1376. PMC: 6708435. DOI: 10.1038/s41395-018-0194-5. View

3.
Wong P, Waggoner D, Subramaniam J, Tessarollo L, Bartnikas T, Culotta V . Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc Natl Acad Sci U S A. 2000; 97(6):2886-91. PMC: 16025. DOI: 10.1073/pnas.040461197. View

4.
Guo T, Kouvonen P, Koh C, Gillet L, Wolski W, Rost H . Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps. Nat Med. 2015; 21(4):407-13. PMC: 4390165. DOI: 10.1038/nm.3807. View

5.
de Roos B, Duthie S, Polley A, Mulholland F, Bouwman F, Heim C . Proteomic methodological recommendations for studies involving human plasma, platelets, and peripheral blood mononuclear cells. J Proteome Res. 2008; 7(6):2280-90. DOI: 10.1021/pr700714x. View